Boston Scientific Corporation (ETR:BSX)
62.00
0.00 (0.00%)
At close: Mar 9, 2026
Boston Scientific Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 91,286 | 120,389 | 127,153 | 76,620 | 62,012 | 53,227 | Upgrade
|
| Market Cap Growth | -38.56% | -5.32% | 65.95% | 23.56% | 16.50% | 26.48% | Upgrade
|
| Enterprise Value | 100,120 | 129,762 | 135,850 | 84,391 | 70,055 | 59,835 | Upgrade
|
| Last Close Price | 62.00 | 81.60 | 87.00 | 51.40 | 43.25 | 38.12 | Upgrade
|
| PE Ratio | 36.98 | 48.78 | 71.04 | 53.94 | 103.23 | 61.46 | Upgrade
|
| PS Ratio | 5.34 | 7.04 | 7.86 | 5.95 | 5.23 | 5.09 | Upgrade
|
| PB Ratio | 4.38 | 5.78 | 5.98 | 4.34 | 3.77 | 3.64 | Upgrade
|
| P/FCF Ratio | 29.30 | 38.64 | 49.77 | 47.26 | 70.65 | 46.00 | Upgrade
|
| P/OCF Ratio | 23.64 | 31.18 | 38.32 | 33.84 | 43.43 | 32.37 | Upgrade
|
| EV/Sales Ratio | 5.78 | 7.59 | 8.40 | 6.55 | 5.90 | 5.72 | Upgrade
|
| EV/EBITDA Ratio | 21.28 | 28.54 | 32.93 | 25.82 | 23.63 | 23.33 | Upgrade
|
| EV/EBIT Ratio | 29.24 | 38.37 | 46.85 | 38.59 | 36.83 | 37.31 | Upgrade
|
| EV/FCF Ratio | 32.14 | 41.65 | 53.17 | 52.05 | 79.82 | 51.71 | Upgrade
|
| Debt / Equity Ratio | 0.49 | 0.49 | 0.51 | 0.49 | 0.53 | 0.57 | Upgrade
|
| Debt / EBITDA Ratio | 2.19 | 2.19 | 2.57 | 2.58 | 2.87 | 3.17 | Upgrade
|
| Debt / FCF Ratio | 3.27 | 3.27 | 4.25 | 5.34 | 9.96 | 7.24 | Upgrade
|
| Net Debt / Equity Ratio | 0.41 | 0.41 | 0.49 | 0.45 | 0.48 | 0.46 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.87 | 1.87 | 2.53 | 2.41 | 2.66 | 2.61 | Upgrade
|
| Net Debt / FCF Ratio | 2.74 | 2.74 | 4.09 | 4.86 | 8.97 | 5.78 | Upgrade
|
| Asset Turnover | 0.48 | 0.48 | 0.45 | 0.42 | 0.39 | 0.38 | Upgrade
|
| Inventory Turnover | 2.18 | 2.18 | 2.00 | 2.02 | 2.30 | 2.54 | Upgrade
|
| Quick Ratio | 0.90 | 0.90 | 0.46 | 0.63 | 0.76 | 0.87 | Upgrade
|
| Current Ratio | 1.62 | 1.62 | 1.08 | 1.32 | 1.52 | 1.48 | Upgrade
|
| Return on Equity (ROE) | 12.45% | 12.45% | 8.88% | 8.58% | 4.08% | 6.52% | Upgrade
|
| Return on Assets (ROA) | 5.98% | 5.98% | 5.04% | 4.47% | 3.93% | 3.62% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.85% | 10.08% | 7.95% | 7.15% | 4.95% | 7.43% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.40% | 10.40% | 9.10% | 8.00% | 7.10% | 6.50% | Upgrade
|
| Earnings Yield | 2.70% | 2.05% | 1.41% | 1.88% | 1.05% | 1.72% | Upgrade
|
| FCF Yield | 3.41% | 2.59% | 2.01% | 2.12% | 1.42% | 2.17% | Upgrade
|
| Payout Ratio | - | - | - | - | 7.88% | 5.28% | Upgrade
|
| Buyback Yield / Dilution | -0.58% | -0.58% | -1.53% | -1.65% | -0.41% | -1.21% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.